Too often, recruiters are more clear on what a position will “do” rather than what it will “achieve”.Outlining tasks and responsibilities takes priority over goals and impact.But to attract top talent, you need to define and explain what success looks…
HOME > TOP STORIES
TOP STORIES
-
ORGANIZATION Wholesale Industry FTC Prohibits Drink Donations at Academic Confabs, Keeps Pace with Drug Makers
January 31, 2013
-
REGULATORY 13 Generic Makers Slapped with Improvement Order due to South Korean Supplier’s GMP Violation
January 30, 2013
-
ORGANIZATION Wholesale Industry FTC Curbs Returns of Drugs to Be Discarded
January 29, 2013
-
BUSINESS Medipal Group Introduces Special Mini Cooler for New Orphan Drug
January 29, 2013
-
REGULATORY PAFSC First Committee on New Drugs to Discuss Approval of Japan’s First FD Treatment
January 28, 2013
-
BUSINESS Novartis, Sanofi Dissolve Partnership on Equa Copromotion
January 25, 2013
-
BUSINESS Transparency GL: Drug Makers Might Disclose Individual Payments Only Upon Request
January 24, 2013
-
BUSINESS Merck Serono Aims for Top 10 Slot in Oncology Field
January 23, 2013
-
BUSINESS Sanofi’s Dellegra Promotion to Home in on Stuffy Nose
January 22, 2013
-
BUSINESS Pfizer Detailing Infectious Disease Portfolios across Divisions
January 21, 2013
-
BUSINESS Drug Makers’ Specialty Care Pipelines Hit Snags in Late-Stage Development
January 21, 2013
-
ORGANIZATION JPMA Bolstering ICH Activities to Propose New Topics from Industry
January 18, 2013
-
BUSINESS Celgene K.K. Focused on MR Training Aiming for No. 1 Ranking Among Hematologists in 2013
January 18, 2013
-
BUSINESS OrphanPacific’s Orphan Drug Biz Faces Rough Going with Rising Costs
January 17, 2013
-
BUSINESS Domestic Drug Makers Working to Escape Dependence on Long-Listed Drugs through New Product Development
January 17, 2013
-
BUSINESS GMP Violations at Drug Substance Makers Prompt Series of New Voluntary Recalls of Generics; Stable Supplies Disrupted
January 16, 2013
-
ORGANIZATION JMA Vice Pres. Nakagawa Urges Pharmacies to Rigidly Check Medical Exam History of Epadel OTC Buyers
January 15, 2013
-
REGULATORY Focus May Be on Whether New Price Cutting Rule for Long-Listed Drugs Should Apply Only to Those Granted Premium
January 15, 2013
-
REGULATORY PMDA Probes How Insurance Pharmacies Utilize Drug Safety Information
January 11, 2013
-
BUSINESS Takeda to Pitch Lotriga for Patients with Residual Event Risks, Cultivate New Market
January 10, 2013
ページ
Pharmaceutical companies are giving high marks to Japan’s drug pricing reform for FY2024. According to a survey conducted by Jiho, 51% of all respondents expressed a positive opinion of the reform, saying that they were “somewhat satisfied” with it. The…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…